Sanz, Iñaki
Emory University School of Medicine,
United States
2024 Rank: 146988
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Arthritis & Rheumatology
Rank in SubField 1: 2768 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 146988 | 166548 |
| Total Cites | 580 | 619 |
| H-index | 12 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 26 | 26 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 240 | 257 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 459 | 477 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.30 |
| Self-Citation Percentage |
6.30%
|
|
Sanz, Iñaki
Emory University,
United States
2023 Rank: 110803
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Arthritis & Rheumatology
Rank in SubField 1: 2310 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 110803 | 128153 |
| Total Cites | 690 | 749 |
| H-index | 15 | 15 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 26 | 26 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 303 | 319 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 544 | 568 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.32 |
| Self-Citation Percentage |
7.88%
|
|
Sanz, Iñaki
Emory University,
United States
2021 Rank: 89676
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Arthritis & Rheumatology
Rank in SubField 1: 2000 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 89676 | 100859 |
| Total Cites | 954 | 1018 |
| H-index | 18 | 18 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 61 | 61 |
| Number of Single+First+Last Authored Papers | 65 | 65 |
| Total Cites to Single+First+Last Authored Papers | 398 | 415 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 759 | 793 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.28 |
| Self-Citation Percentage |
6.29%
|
|
Sanz, Iñaki
Emory University,
United States
2020 Rank: 70290
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Arthritis & Rheumatology
Rank in SubField 1: 1495 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 70290 | 76017 |
| Total Cites | 729 | 801 |
| H-index | 15 | 15 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 15 | 15 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 55 | 57 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 326 | 351 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 567 | 589 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.36 |
| Self-Citation Percentage |
8.99%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.